Table 3.
Predictors of major complication after logistic regression analysis.
| Variable | Wound Disruption |
Major Complication |
Unplanned Reoperation |
Unplanned Readmission |
Surgical Site Infection |
Non-Home Discharge |
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| Age >60 | 0.59 (0.39–0.88)* | 2.52 (2.27–2.79)* | 1.24 (1.11–1.38)* | 2.87 (2.21–3.73)* | 0.7 (0.61–0.81)* | 11.98 (11.46–12.53)* |
| Race | ||||||
| Caucasian (Reference) | ||||||
| African American | 1.34 (0.76–2.35) | 1.25 (1.11–1.41)* | 1.03 (0.87–1.21) | 0.8 (0.54–1.2) | 1.06 (0.86–1.31) | 0.8 (0.74–0.86)* |
| Hispanic | 0.77 (0.28–2.08) | 0.79 (0.66–0.95)* | 0.74 (0.58–0.95)* | 0.46 (0.3–0.72)* | 0.89 (0.65–1.21) | 0.55 (0.5–0.6)* |
| Other | 1.87 (0.95–3.69) | 0.86 (0.72–1.02) | 0.8 (0.63–1.02) | 1.41 (0.65–3.07) | 0.75 (0.53–1.07) | 0.61 (0.56–0.66) * |
| Female | 0.85 (0.61–1.2) | 0.73 (0.69–0.78)* | 0.84 (0.77–0.91)* | 0.89 (0.71–1.11) | 0.82 (0.73–0.92)* | 1.1 (1.06–1.14) * |
| Weight Loss | – | 1.4 (1.13–1.72) * | – | – | – | 1.79 (1.5–2.12) * |
| Preoperative Blood Transfusion | – | 1.45 (1.29–1.63) * | – | – | 1.09 (0.81–1.45) | – |
| Systemic Sepsis | – | 2.05 (1.9–2.22) * | 1.14 (1–1.3) | 1.43 (0.97–2.11) | 1.2 (1–1.45) | 2.33 (2.19–2.49) * |
| Corticosteroid Use | – | 1.32 (1.18–1.49) * | 1.62 (1.38–1.88)* | – | 1.48 (1.17–1.86)* | 1.4 (1.29–1.51) * |
| Open Wound/Wound Infection | 3.29 (2.06–5.26)* | 1.51 (1.35–1.68) * | 2.07 (1.81–2.38) * | – | 2.3 (1.9–2.77)* | 1.19 (1.1–1.29) * |
| On Dialysis | – | 1.8 (1.53–2.11) * | 2.16 (1.74–2.68) * | – | – | 2.49 (2.15–2.88) * |
| Emergency Services Used | – | 1.22 (1.14–1.31) * | 1.15 (1.04–1.26) * | 1.39 (1.05–1.85)* | – | 1.73 (1.67–1.8) * |
| Dyspnea | – | 1.51 (1.37–1.66) * | – | – | – | – |
| Bleeding Disorder | – | 1.34 (1.24–1.45) * | 1.16 (1.03–1.3) * | 1.57 (1.11–2.21)* | 1.24 (1.05–1.47) * | 2.2 (2.09–2.33) * |
| Ascites | – | 3.2 (2.2–4.65) * | 2.8 (1.68–4.64) * | – | – | 3.23 (2.06–5.07) * |
| Current Smoker | 1.51 (1.03–2.22)* | 0.81 (0.6–1.09) | 1.37 (1.24–1.52) * | 1.08 (0.82–1.43) | 1.4 (1.22–1.61) * | – |
| mFI Cohorts | ||||||
| 0 (Reference) | ||||||
| 1 | 2.49 (1.59–3.91)* | 1.55 (1.42–1.7) * | 1.34 (1.21–1.5)* | 1.44 (1.1–1.89)* | 1.41 (1.21–1.64) * | 2.06 (1.98–2.14) * |
| 2 | 2.83 (1.71–4.68)* | 2.04 (1.86–2.24) * | 1.49 (1.33–1.69) * | 1.87 (1.37–2.56)* | 1.77 (1.49–2.09) * | 2.63 (2.51–2.74) * |
| ≥3 | 3.08 (1.55–6.12)* | 3.04 (2.71–3.41) * | 1.57 (1.33–1.85) * | 2.12 (1.36–3.32)* | 1.90 (1.5–2.41) * | 3.06 (2.84–3.31) * |
* significance defined as p < 0.05, - not included due to failure to reach significance with chi square testing.